Sg3 Management, LLC Bausch Health Companies Inc. Call Options Transaction History

Sg3 Management, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	SELL	$6.28 - $9.85 $246,176 - $386,120	-39,200 Closed	0 $0
Q4 2022 Feb 14, 2023	SELL	$6.09 - $7.93 $147,378 - $191,906	-24,200 Reduced 61.73%	15,000 $94,000
Q3 2022 May 15, 2023	BUY	$4.58 - $9.21 $110,836 - $222,882	24,200 Added 161.33%	39,200 $270,000
Q3 2022 Nov 14, 2022	SELL	$4.58 - $9.21 $897,680 - $1.81 Million	-196,000 Reduced 83.33%	39,200 $270,000
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $1.8 Million - $6.03 Million	-255,300 Reduced 52.05%	235,200 $1.97 Million
Q1 2022 May 16, 2022	BUY	$21.6 - $27.79 $6.75 Million - $8.69 Million	312,600 Added 175.72%	490,500 $11.2 Million
Q4 2021 Feb 15, 2022	BUY	$23.0 - $29.01 $1.79 Million - $2.26 Million	77,900 Added 77.9%	177,900 $4.91 Million
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $2.74 Million - $3.27 Million	100,000 New	100,000 $2.93 Million

255

254M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.7B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.